Treatment of allodynia, hyperalgsia, spontaneous pain, and phantom pain
EP2621512A1
Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
EP2621403A1
Implantable cell device with supportive and radial diffusive scaffolding
EP2389191A2
Expression of neuropeptides in mammalian cells
CN102164611A
Therapeutic use of a growth factor, METRNL
US2007128168A1
Novel genes regulated in the developing human ventral mesencephalon
CA2627543A1
Implantable biocompatible immttnoisolatory vehicle for delivery of gdnf
NZ563313A
An implantable therapy system for treating a living being with an active factor
WO2006102902A1
A human immortalised neural precursor cell line
US2008318853A1
Diagnostic and Therapeutic Use of a Novel Growth Factor, Neublasmin
WO2006013462A2
Growth factors nsg28, nsg30, and nsg32
BRPI0509278A
isolated polypeptide, isolated nucleic acid molecule, vector, isolated host cell, packaging cell line, biocompatibly implantable cellular device, pharmaceutical composition, use of the polypeptide, or isolated nucleic acid sequence, or expression vector, or composition of host cells, or a biocompatibly implantable cellular device or a packaging cell line, method of treating a pathological condition in an individual, methods for preventing apoptosis in a mammalian neuronal cell, to enhance the survival of a neuronal cell mammalian cells, to generate a neuron, to expand a mammalian cell composition, and to differentiate a mammalian cell composition, antibody, and, immunoconjugate
US7303912B2
Cultures of GFAP nestin cells that differentiate to neurons
WO2005068498A2
Human therapeutic cells secreting nerve growth factor
WO2005051992A1
Use of neublasmin as a maker for testis cancer
CN1897977A
In vivo gene therapy of parkinson's disease
EP2210617A1
Mammalian cells secreting Neurturin and their therapeutic use
WO2004108760A2
Improved secretion of neublastin
WO2004062554A2
Enhancement of dopaminergic neuron generation and survital
